Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	84.64M
Revenue (ttm)	3.84M
Net Income (ttm)	-21.77M
Shares Out	85.67M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	108,794
Average Volume	126,229
Open	0.9890
Previous Close	0.9880
Day's Range	0.9880 - 1.0160
52-Week Range	0.7240 - 1.5980
Beta	0.59
RSI	47.72
Earnings Date	Nov 12, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 181
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.